⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVCR News
NovoCure Limited Ordinary Shares
Form 8-K
sec.gov
NVCR
Form 8-K/A
sec.gov
NVCR
Nested Therapeutics Reports Initial Encouraging Clinical Activity and Favorable Tolerability of NST-628, a Brain-Penetrant Pan-RAF/MEK Molecular Glue, at AACR 2026
prnewswire.com
NVCR
Form 8-K
sec.gov
NVCR
Gliosarcoma Market Intelligence Report 2026-2030 & 2035: Expansion of Molecular Testing and Increased Research Funding is Driving Industry Growth
globenewswire.com
NVCR
MRK
PFE
ABBV
Glioblastoma Multiforme (GBM) Treatment Market to Grow by $1.44 Billion During 2026-2030: Strategic Analysis of 23 Industry Players
globenewswire.com
NVCR
MRK
PFE
Form 8-K
sec.gov
NVCR
Novocure Announces Positive Topline Results from Phase 2 PANOVA-4 Clinical Trial of Tumor Treating Fields (TTFields) Therapy for Metastatic Pancreatic Cancer
businesswire.com
NVCR
Novacore Appoints Benjamin Piening as President of Real Estate Segment
prnewswire.com
NVCR
Novocure Announces Optune Lua ® Receives Reimbursement Approval in Japan for the Treatment of Non-Small Cell Lung Cancer
businesswire.com
NVCR